IPO Price Range: ₹113 - 119
Min Investment
₹1,42,800
IPO Size
₹73 Cr
IPO Status
Quantity in 1 Lot
1200
Max Bid allowed
1
Listing Exchange
NSE
IPO subscribed over
🚀 58.3817x
This IPO has been subscribed by 34.9989x in retail and 21.2297x in QIB.
Total Subscription | 58.3817x |
Retail Individual Investors | 34.9989x |
Qualified Institutional Buyers | 21.2297x |
Non Institutional Investors | 183.1737x |
![]() | 25 Mar 2025 |
![]() | 27 Mar 2025 |
![]() | 28 Mar 2025 |
![]() | ₹73.81Cr |
![]() | 1200 |
Experienced Promoters and Management Team.
Manufacturing facility supported by technology driven process and R&D capabilities.
Quality Service.
Long term relationship with the clients.
Healthy relationship with Crude Caffeine Suppliers.
The Primary Object to issue is Investment in Wholly Owned Subsidiary which is setting up a manufacturing unit (Proposed Project). Such Proposed Project is subject to the risk of unanticipated delays in implementation, cost overruns and certain Government approvals and licenses. If the company is unable to implement the expansion plans at the planned cost or time or unable to obtain Government approvals and licenses, it could materially and adversely impact its business, results of operations and financial condition.
Its Statutory Auditors have included certain qualifications in the annexure to their audit reports, for half year ended September 30, 2024 and the years ended March 31, 2024, March 31, 2023 and March 31, 2022.
The Company plans to invest an estimated sum of Rs. 3,500 lakhs out of the Net proceeds of the Issue in its Wholly Owned Subsidiary namely Shri Ahimsa Healthcare Private Limited for setting up a manufacturing unit (Proposed Project). Inthe event of any delay in placing these orders, or if the vendors are not able to provide the equipment / machinery or complete the civil and related works etc. in a timely manner, or at all, may result in time and cost over-runs.
A significant majority of its revenues from operations are derived from a limited number of customers.
The company is dependent on third parties for the supply of raw materials and such providers could fail to meet their obligations, which may have a material adverse effect on its business, results of operations and financial condition.
Some of the immediate relatives of its Promoters, who are deemed to be a part of the Promoter Group under SEBI ICDR Regulations have not provided consent and / or any confirmations, undertakings for them to be included as a members of the Promoter Group.
Its cost of production is exposed to fluctuations in the prices of raw material particularly Crude Caffeine and the Company has not entered into any agreement with respect to long-term supply for raw materials required.
Relevant documents of the Secretarial Records are not traceable by the Company.
The Company has not complied with certain financial covenants of the financing facility and debt facility in past.
In the Past, one of its Independent Director, Mr. Rakesh Kumar, was involved in a legal investigation by the Directorate General of GST Intelligence (DGGI).
Investors | Holdings % |
Nemi Chand Jain | 38.72% |
Sumitra Jain | 13.61% |
Amit Kumar Jain | 20.4% |
Sumit Jain | 2.29% |
Ahimsa Holdings Pvt Ltd | 8.09% |